Researchers identified a set of genetic changes that predict whether melanoma patients will respond to checkpoint inhibitor therapies. It’s what’s missing in the tumor genome, not what’s mutated, that thwarts treatment of metastatic melanoma with immune checkpoint blockade drugs, researchers at The University of Texas MD Anderson Cancer Center report in Science Translational Medicine. Whole...
Category: <span>Immunotherapy</span>
Two babies with terminal cancer CURED after 'miracle' treatment
Two British infants, 11 and 16 months old, have been cured of leukemia Both have been in remission for at least a year post-treatment London doctors used genetically engineered immune cells to treat the cancer This could lead to off-the-shelf cellular therapy at a low cost for future patients Two babies who were...
The immunotherapy, pembrolizumab, is active against mucosal melanoma tumors
And prolongs survival for patients with bladder cancer Amsterdam, The Netherlands: Clinical trials of a new immunotherapy, pembrolizumab, have shown that it prolongs life significantly for patients with bladder cancer and is active against a rare sub-type of melanoma, called mucosal melanoma. The findings were presented in two presentations at the European Cancer Congress 2017...
Sufferers of schizophrenia
Sufferers of schizophrenia ‘may have a treatable immune disorder’ that could be completely cured Experts found 1 in 11 psychosis cases involved antibodies attacking the brain Antibodies attacked the ‘NMDA receptor’ – which can cause encephalitis The findings could open up a different route to tackling mental illness, they say By Stephen Matthews For Mailonline...
1 Patient, 7 Tumors and 100 Billion Cells Equal 1 Striking Recovery
There was an exceptional example of a woman who recovered from an advanced colon cancer after being treated with her own cells. This offers new possibilities for other people who suffer from pancreatic or colon cancer. This was the primary example of a successful cancer mutation that the experts have been trying to cure for years....
Novel technologies and emerging bio-markers for personalized cancer Immunotherapy
Abstract The culmination of over a century’s work to understand the role of the immune system in tumor control has led to the recent advances in cancer immunotherapies that have resulted in durable clinical responses in patients with a variety of malignancies. Cancer immunotherapies are rapidly changing traditional treatment paradigms and expanding the therapeutic landscape...
KEYTRUDA WORKS WITH YOUR IMMUNE SYSTEM TO HELP FIGHT CANCER CELLS
KEYTRUDA is not chemotherapy or radiation therapy—it is an immunotherapy and it works with your immune system to help fight certain cancers. KEYTRUDA can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become serious or life-threatening...
- 1
- 2